Monroe Capital (MRCC) Receiving Somewhat Favorable Media Coverage, Study Finds
News headlines about Monroe Capital (NASDAQ:MRCC) have been trending somewhat positive this week, according to Accern Sentiment. Accern identifies negative and positive media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Monroe Capital earned a coverage optimism score of 0.10 on Accern’s scale. Accern also gave headlines about the financial services provider an impact score of 47.6531812242364 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
Here are some of the news headlines that may have effected Accern’s analysis:
- Edited Transcript of MRCC earnings conference call or presentation 8-Aug-18 4:00pm GMT (finance.yahoo.com)
- [$$] Monroe Backs Level Capital’s Recapitalization of S&S HealthCare Strategies (finance.yahoo.com)
- $15.41 Million in Sales Expected for Monroe Capital Corp (MRCC) This Quarter (americanbankingnews.com)
- National Securities Lowers Monroe Capital (MRCC) Price Target to $16.00 (americanbankingnews.com)
- Oppenheimer Research Analysts Increase Earnings Estimates for Monroe Capital Corp (MRCC) (americanbankingnews.com)
NASDAQ MRCC traded down $0.09 on Friday, reaching $13.60. The company’s stock had a trading volume of 40,168 shares, compared to its average volume of 99,272. The stock has a market cap of $280.70 million, a P/E ratio of 9.71 and a beta of 0.69. Monroe Capital has a 52 week low of $12.18 and a 52 week high of $14.80. The company has a quick ratio of 2.08, a current ratio of 2.08 and a debt-to-equity ratio of 0.87.
A number of analysts recently weighed in on MRCC shares. National Securities reissued a “buy” rating and issued a $17.00 target price on shares of Monroe Capital in a research note on Monday, May 14th. BidaskClub raised shares of Monroe Capital from a “buy” rating to a “strong-buy” rating in a research note on Saturday, June 2nd. Zacks Investment Research cut shares of Monroe Capital from a “buy” rating to a “hold” rating in a research note on Thursday, July 26th. Finally, ValuEngine raised shares of Monroe Capital from a “sell” rating to a “hold” rating in a research note on Wednesday, May 23rd. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating to the stock. Monroe Capital presently has an average rating of “Hold” and an average target price of $15.00.
In other news, Director Jeffrey A. Golman acquired 8,000 shares of the firm’s stock in a transaction on Wednesday, June 20th. The shares were purchased at an average cost of $13.62 per share, with a total value of $108,960.00. Following the completion of the purchase, the director now owns 10,000 shares of the company’s stock, valued at $136,200. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 1.90% of the stock is currently owned by corporate insiders.
About Monroe Capital
Monroe Capital Corporation is a business development company specializing in senior, unitranche and junior secured debt and to a lesser extent, unsecured debt and equity investments, and buyouts in middle-market companies. The fund prefers to invest in casinos and gaming, broadcasting, publishing, alcoholic beverage and tobacco distribution, oil and gas, insurance, pharmaceuticals and bio sciences, aerospace and defense, commercial printing, natural rubber, glass, container and packaging, metals and mining, and real estate.
Recommended Story: Technical Analysis of Stocks and What It Means
Receive News & Ratings for Monroe Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monroe Capital and related companies with MarketBeat.com's FREE daily email newsletter.